Article
Exploring the Melanoma and Pancreatic Cancer Phenotype of a Potential CDKN2A Founder Variant, I49T (c.146T>C; p.Ile49Thr), in Individuals of Predominantly Mexican Ancestry.
JCO precision oncology - 1 Sept 2026
Hernandez Daisy, Browning Ashlie, Gemmell Amber, Lara-Otero Karlena, Niell-Swiller Mariana, Mersch Jacqueline, Mraz Kathryn A, Kamara Daniella, Blanco Amie, Cardona Yvonne, Chang Emmeline, Comeaux Jacob G, Culver Julie O, Ford James M, Gutierrez Natalia, Lester Jenny, Karlan Beth Y, Li Ming, Nie Qi, Resendiz Jesus, Wei Maria L, Ricker Charité N
Abstract excerpt
PURPOSE: Pathogenic/likely pathogenic variants (P/LPVs) in the CDKN2A gene cause an increased risk of melanoma (MEL) and pancreatic cancer (PANC). The CDKN2A variant I49T (c.146T>C), reported to be recurrent in Hispanics, has conflicting pathogenicity classifications at laboratories, affecting clinical care. Multiple genetics clinics collaborated to explore cancers associated with I49T. METHODS: Institutional...
Read the complete abstract on PubMedTopics
- Humans
- Pancreatic Neoplasms
- Cyclin-Dependent Kinase Inhibitor p16
